IP

IP Financing Cash Flow

-$1.67BTTM · USD

Period ending:

IP FY Cash from FinancingUSD
IP FY Cash from Financing1989-12-31: $289.00M1990-12-31: $163.00M1991-12-31: $777.00M1992-12-31: $789.00M1993-12-31: $215.00M1994-12-31: $291.00M1995-12-31: $341.00M1996-12-31: $1.28B1997-12-31: -$346.00M1998-12-31: -$546.00M1999-12-31: -$706.00M2000-12-31: $3.39B2001-12-31: -$2.10B2002-12-31: -$1.73B2003-12-31: $591.00M2004-12-31: -$2.44B2005-12-31: -$2.38B2006-12-31: -$2.30B2007-12-31: -$2.25B2008-12-31: $4.86B2009-12-31: -$3.38B2010-12-31: -$588.00M2011-12-31: $742.00M2012-12-31: -$795.00M2013-12-31: -$1.69B2014-12-31: -$2.09B2015-12-31: -$1.60B2016-12-31: $982.00M2017-12-31: -$399.00M2018-12-31: -$2.05B2019-12-31: -$2.39B2020-12-31: -$2.70B2021-12-31: -$7.38B2022-12-31: -$2.05B2023-12-31: -$866.00M2024-12-31: -$775.00M2025-12-31: -$708.00M$4.86B-$7.38B
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

IP financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

International Paper Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
-708,000,000
-775,000,000
-866,000,000
-2,054,000,000
-7,375,000,000
-2,700,000,000
-2,389,000,000
-2,046,000,000
-399,000,000
982,000,000
-1,601,000,000
-2,086,000,000
-1,688,000,000
-795,000,000
742,000,000
-588,000,000
-3,376,000,000
4,859,000,000
-2,252,000,000
-2,304,000,000
-2,377,000,000
-2,435,000,000
591,000,000
-1,732,000,000
-2,098,000,000
3,394,000,000
-706,000,000
-546,000,000
-346,000,000
1,280,000,000
341,000,000
291,000,000
215,000,000
789,000,000
777,000,000
163,000,000
289,000,000

Compare financing cash flow

All IP financial metrics · IP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.